EFTRW

eFFECTOR Therapeutics, Inc. Warrant
EFTRW

Delisted

EFTRW was delisted on the 2nd of July, 2024.

Back to rankings

16 hedge funds and large institutions have $798K invested in eFFECTOR Therapeutics, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$17K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$13K
2
+$2.19K

Top Sellers

1
-$140K
2
-$35K
3
-$6K
4
WAM
Wolverine Asset Management
Illinois
-$3.53K
5
HF
HRT Financial
New York
-$808
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$379K
2
$124K
3
$101K
4
$75K
5
$36K
6
$13K
7
$13K
8
$13K
9
$9K
10
$8K
11
$8K
12
$7K
13
$4K
14
$4K
15
$2.5K
16
$1K
17
–
18
–